Alcon Inc (ALC) Return on Equity ROE from the fourth quarter 2025 to fourth quarter 2024 and annually, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alcon inc   (NYSE: ALC)

Alcon Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Alcon Inc in the fourth quarter 2025?
Alcon inc achieved a return on average equity (ROE) of 5.24 % in its fourth quarter 2025, this is above ALC's average return on equity of 5.23%.
Alcon Inc s equity during the 12 months ending in the fourth quarter 2025 are valued at $22 billion

ROE fell compared to the third quarter 2025, despite the net income growth of % from the third quarter 2025.

Within the Medical Equipment & Supplies industry 58 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2025 from to 2260.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Equity Change 2.24 % 2.24 % 5.68 % 2.24 % -
Y / Y Net Income Change -3.73 % - -21.08 % - 4.52 %
Net Income (TTM) in Millions 1,156 1,194 1,194 1,241 1,241
Return On Equity (TTM) 5.24 % 5.44 % 5.47 % 5.77 % 5.8 %
ALC's Total Ranking # 2260 # # # #
Equity (TTM) in Millions 22,035 22,035 22,130 22,035 21,553
Seq. Equity Change 0 % -0.43 % 0.43 % 2.24 % 0 %
Seq. Net Income Change - - - - -

Back to ALC Management Effectiveness >> ALC's 5 Years Annual ROE >> Compare ALC ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 59
Sector # 195
Overall # 2260

Return On Equity Statistics
High Average Low
30.47 %
5.23 %
-3.4 %
(Dec 31 2010)   (Dec 31 2019)





ALC Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 22,035 21,553 20,624 19,677 19,256
Y / Y Equity Change 2.24 % 4.5 % 4.81 % 2.19 % 2.31 %
Net Income in Millions 980 1,018 974 335 376
Y / Y Net Income Change -3.73 % 4.52 % 190.75 % -10.9 % -
Return On Equity 4.45 % 4.72 % 4.72 % 1.7 % 1.95 %

Back to ALC Management Effectiveness >> ALC's 5 Years Annual ROE >> Compare ALC ROE to its Competitors




Annual Roe Comment
In 2025 ROE decreased compared to the previous year to 4.45 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ALC's' Return on Equity at Yahoo Finance
ALC's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ALC's Competitors
Subscribers only: Roe for Alcon Inc 's Suppliers
Subscribers only: Return On Equity for ALC's Customers




Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector ROE
Keros Therapeutics Inc   14.25 %
Ardent Health Inc   14.09 %
Escalon Medical Corp   13.91 %
Ligand Pharmaceuticals Incorporated  13.86 %
Inmode Ltd   13.73 %
Cadre Holdings inc   13.50 %
Penumbra Inc  13.43 %
Seres Therapeutics Inc   13.30 %
Bioventus Inc   13.26 %
Alpha Pro Tech Ltd   13.17 %
Royalty Pharma Plc  13.11 %
Abbott Laboratories  12.80 %
Amphastar Pharmaceuticals Inc   12.76 %
Nature s Sunshine Products inc   12.41 %
Boston Scientific Corporation  12.41 %
Globus Medical Inc   12.40 %
Nephros Inc   12.22 %
Infusystem Holdings Inc  11.91 %
Healthcare Services Group Inc   11.83 %
Smith and Nephew Plc  11.82 %
National Healthcare Corp  11.77 %
U S Physical Therapy Inc  11.70 %
Kiniksa Pharmaceuticals International Plc  11.48 %
Progyny Inc   11.37 %
Siga Technologies Inc  11.25 %
Qiagen N v   11.25 %
Viemed Healthcare Inc   11.03 %
Hologic Inc  11.01 %
Pacific Health Care Organization Inc  10.99 %
Bio rad Laboratories Inc   10.86 %

Date modified: 2026-09-08T15:11:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.